Custom Synthesis

BASF produces customized active ingredients and advanced intermediates exclusively and in complete confidence on behalf of pharmaceutical companies. BASF’s experts offer support through the drug lifecycle - from kilo laboratory to commercial production, from the early clinical phase to market launch and even when the drug becomes generic.

In 2005 BASF acquired the Swiss fine chemicals company Orgamol, which can boast over fifty years of experience and success in the field of exclusive synthesis. Thanks to this increase in know-how and further production facilities, BASF has come to offer even more comprehensive custom synthesis services. We are now one of the leading companies in this sector.